And heres something you might not have heard from your allergist: Low-Dose Naltrexone (LDN) could be part of your solution
Prebiotics can be used to promote metabolic health and longevity by stimulating intestinal production of GLP-1, and so too can the drug Acarbose, which acts as a starch blocker, inhibiting the enzymes that would normally digest carbohydrates earlier in the small intestine
Moreover, ferroptosis is increasingly recognized as an important driver of disease pathogenesis, including but not limited to cancer, degenerative diseases, ischemic injury, and infections [25]
A prescription can only be issued following a clinical evaluation and not an online questionnaire alone
Conversely, targeting GLP-1 signaling could help develop more personalized treatment approaches for NMOSD and APS
But of course, with new treatments, there are always questions: Does it work